Apoptos

Apoptos, Inc. is a San Diego-based biopharmaceutical company focused on novel small-molecule drug therapies that induce tumor cell apoptosis. By leveraging innovative technologies licensed from the Burnham Institute for Medical Research, the Fred Hutchinson Cancer Research Center, and the Torrey Pines Molecular Institute, the company collaborates closely with leading scientists in the field of apoptosis to develop an anti-cancer platform. In addition to cancer, Apoptos’ technology holds promise for applications in other medical fields, including autoimmune diseases and inflammation.